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I nterdisciplinary research and educationare key for a better appreciation of sexand gender as defining a person, and for
novel societal and personalized health-care
approaches. While the involvement of
abnormal Androgen Receptor (AR) signal-
ling in prostate cancer is well established,
there is growing evidence that it also plays a
role in various other malignancies. A key
target organ for epigenetic modification is
the human brain, which has anatomical dif-
ferences in various regions between men
and women. While significant research is
underway to better understand the factors
that determine sex and gender, other essen-
tial health-related issues for transgender
patients are much less well studied.
Sex and gender are different characteris-
tics and yet inextricably linked to the human
experience in determining bodily, mental
and social activities. Sex refers to the biolog-
ical and physical features linked with repro-
ductive functions that result from the
combined action of sex chromosomes and
hormones. Gender refers more widely to an
individual’s self-perception and representa-
tion as male, female or non-binary and their
place in society. Historically, the health
sciences have kept sex and gender separated
as biological and societal factors. However,
there are increasing biological as well as
medical arguments to question whether
there is a true divide between the two.
Personalized prevention and treatment of a
large number of medical conditions critically
depends on a better appreciation of both the
physiological difference between the biologi-
cal sexes and how male, female and non-
binary identities are attained and main-
tained. In fact, sex and gender are at
the interface between environmental and
hormonal factors and genetic and epigenetic
determinants of organ development, most
notably the brain. Interdisciplinary research
and education are key for a better
appreciation of sex and gender as defining a
person, and for novel societal and personal-
ized health-care approaches.
The role of the Y
It is commonly known that the presence of
the male Y chromosome triggers a cascade of
events resulting in male sex development,
with female determination occurring by
default (Wijchers & Festenstein, 2011;
Arnold, 2012). Less appreciated is the fact
that the genetic information carried by the Y
chromosome is minuscule relative to that
stored in the X chromosome and that only
the single SRY gene, buried in a condensed
dormant region of the Y chromosome, drives
the whole male sex determination process
(Waters et al, 2007). The SRY-coded protein,
also called the testis-determining factor
(TDF), is expressed for only a brief moment
during embryo development. Its function is
to bend the curvature of the DNA at a speci-
fic site on a separate chromosome, leading to
the persistently elevated expression of a
second protein, SOX9. This transcription
factor is responsible for converting initially
equivalent cells, present in what will become
the kidney secretory apparatus (mesone-
phros), into cells of the male gonads. SOX9 is
also expressed during development in many
other parts of the embryo, in both males and
females, and fulfils a number of functions
unrelated to sex determination.
There are many clinical examples of the
importance of this sex-determining axis.
Patients with loss of either the SRY or SOX9
gene have a fully female phenotype even if
they carry the Y chromosome (Waters et al,
2007; Wijchers & Festenstein, 2011; Arnold,
2012). Conversely, patients with transloca-
tion of the SRY gene to an autosomal chro-
mosome exhibit a male phenotype in spite
of carrying two X chromosomes. It can be
argued that these are rare genetic syndromes
that can be largely ignored by the general
population, even within the medical profes-
sion. However, clinical syndromes with
similar dissociation between sex chromo-
somes and male versus female phenotypes
occur as a result of inactivating mutations of
another gene of key importance for many
other aspects of human health and beha-
viour: the gene coding for the AR (Hughes
et al, 2012). This protein, expressed in cells
of all types and functions, senses and
responds to androgens, steroid hormones
named for their “male-determining” func-
tion. Testosterone, and its more potent
form dihydrotestosterone (DHT), is the
quintessential androgen produced by
specialized testicular cells, and it instructs
the development of all secondary male sex
organs and other male phenotypic character-
istics, ranging from musculoskeletal mass to
behavioural traits. Inactivating mutations of
the AR gene, or of the gene encoding for the
enzyme involved in testosterone modifi-
cation (5a-reductase), result in individuals
with a non-binary or female phenotype even
in the presence of a XY genotype and testos-
terone-producing testicles (Hughes et al,
2012).
A dance of hormones
Importantly, AR fulfils pleiotropic functions
besides sex determination and is activated
by a variety of other androgens besides
testosterone, which are produced in both
sexes. Diminishing levels of androgens
contribute significantly to age-associated
decline of multiple functions. Changes in AR
activity also bridge the divide between the
two sexes in disease. While the involvement
of abnormal AR signalling in prostate cancer
is well established, there is growing
evidence that it also plays a role in various
other malignancies—specifically breast and
lung cancer (Clocchiatti et al, 2016).
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The localization of the AR gene on the X
chromosome also dispels any notion that AR
fulfils only male-determining functions.
While random X chromosome inactivation
ensures that AR expression is similar in both
sexes, males with a single copy of the gene
are twice more susceptible to deleterious
mutations (Hughes et al, 2012). The Y chro-
mosome is also not neutral, as a number of
genes on it, including SRY, may function as
positive determinants of AR expression and/
or activity. In this context, AR signalling
could be preferentially affected by the
frequent and poorly understood loss of the Y
chromosome that occurs in the male popula-
tion, in ageing tissues and cancer cells (Cloc-
chiatti et al, 2016).
As mentioned above, the absence of the
SRY-SOX9 regulatory axis will result in the
formation of ovaries instead of testicles, while
the production of female sex hormones,
specifically estrogens, drives secondary
female sex organ development. Estrogens
play an opposite role to androgens in many
other biological contexts and, like androgens,
are secreted in both men and women.
Perhaps less known is the biochemical and
functional interconnection and, to some
extent, interchangeability between male and
female sex hormones. Estrogens are metaboli-
cally derived from androgens, while derivates
of another key female hormone, proges-
terone, can exert androgenic functions.
The end point of this complex interplay
between sex chromosomes and hormones is
at the level of epigenetic modifications
(Wijchers & Festenstein, 2011). Compared to
the more permanent differences established
during embryonic development, epigenetic
marks are established later in life and can be
partially reversed. A key target organ for
epigenetic modification is the human brain,
which has anatomical differences in various
regions between men and women (Hines,
2011). These are not associated with any atti-
tudinal and cognitive differences of statistical
significance between the two sexes. By
contrast, there seems to be a link with gender
self-representation, which can already be
documented in children of very young age,
using game preferences as a reliable parame-
ter (Hines, 2011).
Effects on brain development
From all of the above, it follows that
“gender”, as a person’s self-representation
as male or female, may or may not coincide
with “sex”, as a more biological dimension
characterized by sex chromosomes, gonads
and resulting anatomical features. Dif-
ferences in specific brain regions have been
associated with gender self-representation,
including the third interstitial nucleus of the
anterior hypothalamus, (INAH-3), which
tends to be larger in males than in females
(Hines, 2011).
How these anatomical differences are
connected with gender self-representation
and associated sex orientation remains a
mystery. What seems clear, however, is the
role of androgens as endogenous/exogenous
factors that determine gender self-representa-
tion as early as during embryonic develop-
ment, with effects that may persist
throughout the entire life (Hines, 2011;
Goldstein et al, 2019). Adding an additional
twist of complexity, androgens have been
reported to exert their impact on brain
development directly or indirectly, through
their conversion into estrogens. Irrespective
of the detailed mechanisms, the self-repre-
sentation of children born of mothers with
endocrine syndromes has led to the conclu-
sion—supported by parallel studies of
experimental animal systems—that expo-
sure of the developing embryo to elevated
androgen levels leads to male self-identifi-
cation and female self-identification in the
opposite case.
The early impact of androgens on brain
development can be modified or reinforced
later in life by a variety of endogenous and
exogenous factors, but it is hard to revert
(Hines, 2011; Goldstein et al, 2019). An irre-
versible set of events occurring during
embryonic life may be at the basis of gender
dysphoria, a partial or complete dissociation
between the gender self-representation of an
individual and his/her genetic and gonadal
sex (Wanta & Unger, 2017). Those who
identify as transgender may therefore choose
to affirm their gender by hormonal or surgi-
cal intervention to alter their biological sex.
However, it is important not only for gender
identity clinics to assist with psychological
and social transition, along with surgical
and hormonal changes to physical character-
istics.
Addressing sex- and gender-related
health issues
While significant research is underway to
better understand the factors that determine
sex and gender, and how to alleviate gender
dysphoria, other essential health-related
issues for transgender patients are much less
well studied (Wanta & Unger, 2017). There
are some data on the long-term impact of
cross-sex hormones in transgender patients,
though further exploration is required. Simi-
larly, the consequences on age-associated
incidence and progression of various cancer
types, immune/inflammatory diseases and
cardiovascular function are severely under-
studied, in spite of the major impact that
androgens and estrogens have in all these
contexts. Also important is to understand
the effects of androgens and other
substances with sex hormone activity to
which the developing human embryo is
exposed. Endocrine disruptors, chemical
substances that are ubiquitous in the envi-
ronment and that have the ability to block,
induce or interfere with the activity of
endogenous sex hormones, can be easily
transferred from the mother to the develop-
ing embryo with effects that persist into
adult life (Messerlian et al, 2017).
Addressing these challenges will require
more communication and collaboration
among molecular biologists who study
sex-determining molecules and their
effects on human physiology and beha-
viour with specialists who are familiar
with gender-related psychological and
societal issues. Interdisciplinary research,
a generally recognized and attractive prin-
ciple, is key for such an endeavour, but
there are scant support mechanisms. It can
be fairly stated that molecular biologists
and geneticists very rarely if ever read
journals or attend meetings focused on
psychological, social or environmental
issues and vice versa. Epidemiology, classi-
cally defined as “the study of the distribu-
tion and determinants of health-related
states or events”, may hold the key to
bridging this gap. I am a basic molecular/
cell biologist, and it is from epidemiolo-
gists that I learnt of the substantially dif-
ferent susceptibility of men versus women
to various cancer types, and the unmet
need to investigate the long-term health
risks of prolonged exposure to exogenous
and endogenous sex hormones and related
compounds.
Moreover, as a teacher, I also feel that we
have a specific responsibility to point out such
challenges and questions and to raise aware-
ness for the next generation of scientists.
While it is essential for students and
researchers to stay focused at an early stage of
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their career in order to be effective and move
forward, scientists are increasingly called on
to tackle societal issues. Young researchers’
drive and enthusiasm to explore the unknown
is an invaluable treasure; they, even more
than their senior colleagues, should be
encouraged to leave the comfort zone of estab-
lished research fields and venture into new
territory. Disentangling the complex relation-
ship between sex and gender, between genes
and hormones, self-perceptions, disease risk
and social attitudes and expectations would
be a worthy challenge to take on.
Acknowledgements
The author would like to thank Drs. Berna
Ozdemir and Alison May Berner for critical reading
of the manuscript. Related research work in his
laboratory is supported by grants from the
National Institutes of Health (R01AR039190;
R01AR064786; the content not necessarily repre-
senting the official views of NIH), the Swiss
National Science Foundation (310030B_176404,
“Genomic instability and evolution in cancer stro-
mal cells”) and the European Research Council
(26075083) to GPD.
References
Arnold AP (2012) The end of gonad-centric sex
determination in mammals. Trends Genet 28:
55 – 61
Clocchiatti A, Cora E, Zhang Y, Dotto GP (2016)
Sexual dimorphism in cancer. Nat Rev Cancer
16: 330 – 339
Goldstein JM, Hale T, Foster SL, Tobet SA, Handa RJ
(2019) Sex differences in major depression and
comorbidity of cardiometabolic disorders:
impact of prenatal stress and immune
exposures. Neuropsychopharmacology 44:
59 – 70
Hines M (2011) Gender development and the
human brain. Annu Rev Neurosci 34: 69 – 88
Hughes IA, Davies JD, Bunch TI, Pasterski V,
Mastroyannopoulou K, MacDougall J (2012)
Androgen insensitivity syndrome. Lancet 380:
1419 – 1428
Messerlian C, Martinez RM, Hauser R, Baccarelli
AA (2017) ‘Omics’ and endocrine-disrupting
chemicals – new paths forward. Nat Rev
Endocrinol 13: 740 – 748
Wanta JW, Unger CA (2017) Review of the
transgender literature: where do we go from
here? Transgend Health 2: 119 – 128
Waters PD, Wallis MC, Marshall Graves JA (2007)
Mammalian sex–origin and evolution of the Y
chromosome and SRY. Semin Cell Dev Biol 18:
389 – 400
Wijchers PJ, Festenstein RJ (2011) Epigenetic
regulation of autosomal gene expression
by sex chromosomes. Trends Genet 27:
132 – 140
License: This is an open access article under the
terms of the Creative Commons Attribution 4.0
License, which permits use, distribution and repro-
duction in any medium, provided the original work
is properly cited.
ª 2019 The Author EMBO Molecular Medicine 11: e10668 | 2019 3 of 3
Gian-Paolo Dotto EMBO Molecular Medicine
Published online: April 12, 2019 
